Form 4 for HCSG HEALTHCARE SERVICES GROUP INC
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0001704092-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-26 | 2026-02-24 | HCSG | Kush Andrew | EVP, COO | M - OptEx | $0.00 | +17.0K | 32.9K | +107% | $0 |
| DM | 2026-02-26 | 2026-02-24 | HCSG | Kush Andrew | EVP, COO | F - Tax | $21.40 | -7,227 | 31.1K | -19% | -$154.7K |
| D | 2026-02-26 | 2026-02-24 | HCSG | Kush Andrew | EVP, COO | M - OptEx | $0.00 | -4,416 | 8,830 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | M | A | 12,618 | $0.00 | 43,692 | D | — | — | (F2) Represents common stock earned and delivered on a performance stock unit award previously granted in February 2023, based on the satisfaction of certain financial performance criteria for the period ended December 31, 2025. The Company's Nominating, Compensation and Stock Option Committee certified the level of performance-goal attainment on February 24, 2026 and the shares vested upon certification. |
| 2 | Common | Common Stock | 2026-02-24 | F | D | 5,353 | $21.40 | 38,339 | D | — | — | (F1) Represents shares withheld to pay taxes. |
| 3 | Common | Common Stock | 2026-02-24 | F | D | 1,874 | $21.40 | 31,074 | D | — | — | (F1) Represents shares withheld to pay taxes. |
| 4 | Common | Common Stock | 2026-02-24 | M | A | 4,416 | $0.00 | 32,948 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2026-02-24 | M | D | 4,416 | $0.00 | 8,830 | D | — · — to — | 4,416 Common Stock | (F3) Shares issued at the conversion rate of 1-for-1. (F4) These Restricted Stock Units shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the February 24, 2023 grant date. |